What is Genotropin?
Genotropin is Pfizer’s brand of somatropin, recombinant human growth hormone.
Compare our listed 5.3 mg and 12 mg Genotropin presentations. Americans may recognize the U.S. Genotropin Pen 5 (5 mg) and Pen 12 (12 mg) systems. A 5.3 mg international presentation should not be relabeled as the U.S. 5 mg cartridge.
Pfizer’s current U.S. labeling identifies a 5 mg cartridge for Genotropin Pen 5 and a 12 mg cartridge for Genotropin Pen 12. The listed 5.3 mg presentation is separately labeled for its market. Do not assume a 5.3 mg cartridge is interchangeable with the U.S. 5 mg device.
Our first listed presentation is labeled 5.3 mg; it is not being represented as the U.S. 5 mg Genotropin cartridge.
Approximately 16 IU • presentation labeling varies by market
| Quantity | Price per unit | Total price |
|---|---|---|
| 2 units | $420 each | $840 |
| 4 units | $400 each | $1,600 |
| 6 units | $370 eachbest value | $2,220 |
Approximately 36 IU total per unit
| Quantity | Price per unit | Total price |
|---|---|---|
| 1 unit | $840 each | $840 |
| 3 units | $820 each | $2,460 |
| 5 units | $800 eachbest value | $4,000 |
Short answers to the questions that come up before the detailed FAQ or a phone call.
Genotropin is Pfizer’s brand of somatropin, recombinant human growth hormone.
Current U.S. labeling identifies Pharmacia & Upjohn Company LLC, a Pfizer company.
Presentation labeling varies by market. Current U.S. labeling lists a 5 mg cartridge; 5.3 mg presentations are used in other markets.
Yes. Genotropin is FDA approved in the United States for specific pediatric conditions and adult growth hormone deficiency.
Genotropin is a Pfizer somatropin product manufactured by Pharmacia & Upjohn, a Pfizer company.
U.S. labeling includes 5 mg and 12 mg two-chamber cartridges used with matching Genotropin Pen devices, plus MiniQuick single-dose presentations.
Genotropin cartridge strengths are matched to specific reusable pen devices. The cartridge and pen system need to correspond correctly.
Genotropin’s European authorization history reaches back to Denmark in 1987, and the brand’s initial U.S. approval dates to 1987. It is one of the long-established recombinant somatropin brands still recognized today.
Initial U.S. approval: 1987. Pfizer U.S. prescribing information ↗
Product name and device references: Pfizer: Genotropin labeling and devices
We show the brand, presentation and price clearly. If treatment is being considered, a licensed physician can review the clinical information and determine whether somatropin is medically appropriate.
English-speaking patient support can answer product, pricing and logistics questions. When treatment is being considered, Dr. Manuel Aguirre Muñoz can review the medical information and explain the next step.
Device compatibility should never be assumed from similar numbers. U.S. labeling specifies a 5 mg cartridge for Genotropin Pen 5. The 5.3 mg presentation requires verification against the exact product and compatible device.
Yes. Genotropin is prescription-only somatropin.
They are market-specific presentations of the same brand, but the labeling is not identical. The dispensed product should match its local label and prescription.
It is recombinant human growth hormone: somatropin produced using recombinant-DNA technology.
The active ingredient may be the same, while device design, concentration, presentation, excipients, market availability and price can differ.
Compare the pharmaceutical product first. If you want to go further, our English-speaking patient team can explain current availability, logistics and the medical evaluation process.
Review presentations, manufacturers, and delivery devices side by side.
Compare brands →Understand the difference between daily somatropin and long-acting GH products.
Weekly HGH guide →